rs203687

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000186.4(CFH):​c.1337-8595C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.707 in 152,066 control chromosomes in the GnomAD database, including 39,816 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.71 ( 39816 hom., cov: 32)

Consequence

CFH
NM_000186.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.247

Publications

13 publications found
Variant links:
Genes affected
CFH (HGNC:4883): (complement factor H) This gene is a member of the Regulator of Complement Activation (RCA) gene cluster and encodes a protein with twenty short consensus repeat (SCR) domains. This protein is secreted into the bloodstream and has an essential role in the regulation of complement activation, restricting this innate defense mechanism to microbial infections. Mutations in this gene have been associated with hemolytic-uremic syndrome (HUS) and chronic hypocomplementemic nephropathy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Oct 2011]
CFH Gene-Disease associations (from GenCC):
  • primary membranoproliferative glomerulonephritis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • atypical hemolytic-uremic syndrome
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • hemolytic uremic syndrome, atypical, susceptibility to, 1
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • complement factor H deficiency
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • basal laminar drusen
    Inheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Doyne honeycomb retinal dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dense deposit disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BP6
Variant 1-196705140-C-T is Benign according to our data. Variant chr1-196705140-C-T is described in ClinVar as Benign. ClinVar VariationId is 1712366.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.926 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CFHNM_000186.4 linkc.1337-8595C>T intron_variant Intron 9 of 21 ENST00000367429.9 NP_000177.2 P08603A0A024R962

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CFHENST00000367429.9 linkc.1337-8595C>T intron_variant Intron 9 of 21 1 NM_000186.4 ENSP00000356399.4 P08603
ENSG00000289697ENST00000696032.1 linkc.1337-8595C>T intron_variant Intron 9 of 26 ENSP00000512341.1 A0A8Q3SIA1

Frequencies

GnomAD3 genomes
AF:
0.707
AC:
107368
AN:
151948
Hom.:
39760
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.914
Gnomad AMI
AF:
0.513
Gnomad AMR
AF:
0.759
Gnomad ASJ
AF:
0.668
Gnomad EAS
AF:
0.948
Gnomad SAS
AF:
0.710
Gnomad FIN
AF:
0.544
Gnomad MID
AF:
0.668
Gnomad NFE
AF:
0.580
Gnomad OTH
AF:
0.712
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.707
AC:
107479
AN:
152066
Hom.:
39816
Cov.:
32
AF XY:
0.709
AC XY:
52666
AN XY:
74304
show subpopulations
African (AFR)
AF:
0.914
AC:
37953
AN:
41508
American (AMR)
AF:
0.760
AC:
11596
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.668
AC:
2319
AN:
3470
East Asian (EAS)
AF:
0.948
AC:
4901
AN:
5170
South Asian (SAS)
AF:
0.710
AC:
3428
AN:
4830
European-Finnish (FIN)
AF:
0.544
AC:
5726
AN:
10524
Middle Eastern (MID)
AF:
0.663
AC:
195
AN:
294
European-Non Finnish (NFE)
AF:
0.579
AC:
39392
AN:
67982
Other (OTH)
AF:
0.711
AC:
1502
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1447
2895
4342
5790
7237
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
802
1604
2406
3208
4010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.692
Hom.:
6689
Bravo
AF:
0.735
Asia WGS
AF:
0.795
AC:
2764
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Kidney disorder Benign:1
Dec 12, 2016
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.2
DANN
Benign
0.51
PhyloP100
-0.25
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs203687; hg19: chr1-196674270; API